Program Schedule

Vaccines: Pneumococcal

Friday, October 10, 2014: 12:30 PM-2:00 PM
Room: The Pennsylvania Convention Center: IDExpo Hall BC

Tracks: Adult ID, Pediatric ID

Serotype Distribution of S. pneumoniae Community Acquired Pneumonia (CAP) in Adults in the Netherlands in the CAPiTA (Community-Acquired Pneumonia Immunization Trial In Adults) Study Period
Rosalind Hollingsworth, PhD ; Susanne M Huijts, MD ; Marieke Bolkenbaas, MD ; Chris Webber, MD, PhD ; Samantha Gault, Msc ; Scott D. Patterson, PhD ; William Gruber, MD ; Diederick E. Grobbee, MD, PhD ; Marc Bonten, MD PhD
  • PAP14187.3030.pdf (954.3 kB)
  • Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in the elderly
    Kyung-Hyo Kim, M.D. ; Han Wool Kim, M.D. ; Jong Gyun Ahn, M.D.
  • 2014 IDSA poster PDF.pdf (1.3 MB)
  • Regional Differences in Adult Invasive Pneumococcal Disease (IPD) Rates in Tennessee (TN)
    Annabelle De St. Maurice, M.D. ; Natasha Halasa, MD, MPH ; Chris Fonnesbeck, PhD ; William Schaffner, MD ; Carlos G. Grijalva, MD, MPH
    Pneumococcal Vaccination Coverage In The Elderly In The United States: Missed Opportunities Continue
    H. Keri Yang, PhD, MPH, MS ; Changxia Shao, PhD ; John D. Grabenstein, RPh, PhD ; Dongmu Zhang, PHD
    Invasive Pneumococcal Disease in Children with Underlying Conditions Has Higher Case Fatality and Unique Serotype Distribution
    Inci Yildirim, MD, MSc ; Kimberly M. Shea, PhD, MPH ; Brent A. Little, PhD ; Amy Silverio, BS ; Katherine Hsu, MD, MPH ; Stephen I. Pelton, MD
  • Poster 1095 Yildirim et al.pdf (667.0 kB)
  • Impact of Universal Pneumococal Vaccination in Children in Argentina
    Eduardo L. López ; Eduardo Glatstein ; Gustavo C. Ezcurra ; Eduardo Teplitz ; Marisa Iacono ; Analía Garnero ; Daniela Lazzarini ; Miryam Vázquez ; María M. Contrini
  • Poster 1096 - IDWEEK 2014.pdf (351.1 kB)
  • Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
    H. Keri Yang, PhD, MPH, MS ; John D. Grabenstein, RPh, PhD ; Erik J. Dasbach, PhD
    The Immunogenicity of PCV13 compared to PPSV23 in Immunocompetent Older Adults with Stable High Risk Conditions
    Beate Schmoele-Thoma, MD ; Lisa A. Jackson, MD ; Richard N. Greenberg, MD ; Robert Frenck, MD ; Alejandra Gurtman, MD ; Raul E. Isturiz ; Vani Sundaraiyer, PhD ; William Gruber, MD ; Daniel A. Scott, MD
  • PAP14187.3027.pdf (1.0 MB)
  • 13-valent Pneumococcal Conjugate Vaccine Efficacy is Declining with Old Age: Results from an Exploratory Analysis of the CAPiTA Trial
    Cornelis H Van Werkhoven, MD ; Susanne M Huijts, MD ; Marieke Bolkenbaas, MD ; Chris Webber, MD, PhD ; Beate Schmoele-Thoma, MD ; Scott D. Patterson, PhD ; William Gruber, MD ; Diederick E. Grobbee, MD, PhD ; Marc Bonten, MD PhD
  • idweek_poster_ve_by_age_v3.pdf (393.7 kB)
  • The Gap Widens:  Invasive Pneumococcal Serotype Distribution among Adults
    John D. Grabenstein, RPh, PhD ; Melvin a. Kohn, MD, MPH ; David J. Weber, MD, MPH, FIDSA, FSHEA
    Immunogenicity and Safety of a Second Administration of 13-Valent Pneumococcal Conjugate Vaccine Five Years after Initial Vaccination in Adults 50 Years and Older
    Robert W. Frenck Jr., MD ; Anne Fiquet, MD ; Alejandra Gurtman, MD ; Martin Van Cleeff, MD ; Matthew Davis, MD ; John Rubino, MD ; William Smith, MD ; Vani Sundaraiyer, PhD ; Mohinder Sidhu, PhD ; Emilio A. Emini, PhD ; William C. Gruber, MD ; Daniel A. Scott, MD ; Beate Schmoele-Thoma, MD
  • PAP14187.3028.pdf (1.1 MB)
  • Immunogenicity of 13-valent conjugate pneumococcal vaccine in patients 50 years or older with end stage renal disease on dialysis
    Subhashis Mitra, MD ; Gary E. Stein, PharmD ; Daniel H. Havlichek, MD, FIDSA ; Shyam Bhupalam, MD ; Amy Scharmen, BS
    13-Valent Pneumococcal Conjugate Vaccine (PCV13) Immunogenicity in the Community Acquired  Pneumonia Immunization Trial In Adults (CAPiTA)
    Anna M.M. Van Deursen, MD ; Elisabeth a.M. Sanders, MD, PhD ; Chris Webber, MD, PhD ; Michael Patton ; Daniel a. Scott, MD ; Mohinder Sidhu ; Wayne Drews ; Marc Bonten, MD PhD
  • PAP14187.3029_Final.pdf (1.5 MB)
  • Chronic Kidney Disease and Invasive Pneumococcal Disease in Adults
    Roger Baxter, MD ; Arnold Yee, MBA ; Bruce Fireman, MA ; Nicola P. Klein, MD, PhD ; Charlie Chao ; Laurie Aukes, RN ; Stephen I. Pelton, MD ; Bruce Atkinson, PhD ; Chris Paap, Pharm D ; Dial Hewlett Jr., MD ; Vincenza Snow, MD
  • PAP14187.5331.pdf (997.6 kB)
  • Modeling of nasopharyngeal acquisition as a function of anti-capsular serum antibody concentrations and of ethnicity after vaccination with pneumococcal conjugate vaccines (PCVs)
    Ron Dagan, MD ; Christine Juergens, MD ; James Trammel ; Scott D. Patterson, PhD ; David Greenberg, MD ; Noga Givon-Lavi, PhD ; Nurith Porat ; William C. Gruber, MD ; Daniel A. Scott, MD
  • PIP14186.3026.pdf (1.0 MB)
  • Could Disparities in Childhood PCV Adherence Become Disparities in Pneumococcal Disease Rates Under a Reduced Schedule?
    John M. Mclaughlin, PhD, MSPH ; Verna L. Welch, PhD, MPH ; Edward Power, PhD, MBA ; Gregg Sylvester, MD, MPH
  • 1107_McLaughlin_IDWeek.pdf (372.5 kB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, All Rights Reserved.

    Follow IDWeek